Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,000 shares at $267.19 ($819K) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Scheduled sale ($819k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.19 | 100 | $27K | 3.3% |
| 2 | $272.99 | 2,600 | $710K | 86.7% |
| 3 | $274.06 | 300 | $82K | 10.0% |
| Total | $272.90 avg | 3,000 | $819K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-06-03 | $655K | — | Filing → |